Ganesh Kayastha

T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistance

Richard Piekarz, Robert W. Robey, Zhirong Zhan et al. · Blood · 2004 · 187 citations · Full text

Increased <i>MDR1</i> Expression in Normal and Malignant Peripheral Blood Mononuclear Cells Obtained from Patients Receiving Depsipeptide (FR901228, FK228, NSC630176)

Robert W. Robey, Zhirong Zhan, Richard Piekarz et al. · Clinical Cancer Research · 2006 · 98 citations · Full text

Depletion of Mutant p53 and Cytotoxicity of Histone Deacetylase Inhibitors

Mikhail V. Blagosklonny, Shana Y. Trostel, Ganesh Kayastha et al. · Cancer Research · 2005 · 84 citations · Full text

Caspase-dependent deubiquitination of monoubiquitinated nucleosomal histone H2A induced by diverse apoptogenic stimuli

Edward G. Mimnaugh, Ganesh Kayastha, Nathan McGovern et al. · Cell Death and Differentiation · 2001 · 61 citations · Full text

Chromatin, Genome Instability, Chromatin Structure +13

Effect of the proteasome inhibitor ALLnL on cisplatin sensitivity in human ovarian tumor cells

M K Yunmbam, Qingdi Li, Edward G. Mimnaugh et al. · International Journal of Oncology · 2001 · 21 citations

Cisplatin Sensitivity, Endocrine-related Cancer, Proteasome Inhibitor Allnl +15